210 related articles for article (PubMed ID: 23085595)
1. Redox-active cytotoxic diorganotin(IV) cycloalkylhydroxamate complexes with different ring sizes: reduction behaviour and theoretical interpretation.
Shang X; Alegria EC; Guedes da Silva MF; Kuznetsov ML; Li Q; Pombeiro AJ
J Inorg Biochem; 2012 Dec; 117():147-56. PubMed ID: 23085595
[TBL] [Abstract][Full Text] [Related]
2. Polynuclear diorganotin(IV) complexes with arylhydroxamates: Syntheses, structures and in vitro cytotoxic activities.
Shang X; Cui J; Wu J; Pombeiro AJ; Li Q
J Inorg Biochem; 2008 Apr; 102(4):901-9. PubMed ID: 18234346
[TBL] [Abstract][Full Text] [Related]
3. Novel di-n-butyltin(IV) derivatives: Synthesis, high levels of cytotoxicity in tumor cells and the induction of apoptosis in KB cancer cells.
Shang X; Ding N; Xiang G
Eur J Med Chem; 2012 Feb; 48():305-12. PubMed ID: 22226547
[TBL] [Abstract][Full Text] [Related]
4. Syntheses, molecular structures, electrochemical behavior, theoretical study, and antitumor activities of organotin(IV) complexes containing 1-(4-chlorophenyl)-1-cyclopentanecarboxylato ligands.
Shang X; Meng X; Alegria EC; Li Q; Guedes da Silva MF; Kuznetsov ML; Pombeiro AJ
Inorg Chem; 2011 Sep; 50(17):8158-67. PubMed ID: 21793560
[TBL] [Abstract][Full Text] [Related]
5. Diorganotin(IV) derivatives of substituted benzohydroxamic acids with high antitumor activity.
Li Q; da Silva MF; Pombeiro AJ
Chemistry; 2004 Mar; 10(6):1456-62. PubMed ID: 15034889
[TBL] [Abstract][Full Text] [Related]
6. Diorganotin(IV) complexes of dipeptides containing the alpha-aminoisobutyryl residue (Aib): preparation, structural characterization, antibacterial and antiproliferative activities of [(n-Bu)2 Sn(H(-1)L)] (LH=H-Aib-L-Leu-OH, H-Aib-L-Ala-OH).
Katsoulakou E; Tiliakos M; Papaefstathiou G; Terzis A; Raptopoulou C; Geromichalos G; Papazisis K; Papi R; Pantazaki A; Kyriakidis D; Cordopatis P; Manessi-Zoupa E
J Inorg Biochem; 2008 Jul; 102(7):1397-405. PubMed ID: 18289688
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, structural characterization and in vitro cytotoxicity of diorganotin (IV) diimido complexes.
Yin H; Yue C; Hong M; Cui J; Wu Q; Zhang X
Eur J Med Chem; 2012 Dec; 58():533-42. PubMed ID: 23164659
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, crystal structures, cytotoxicity and qualitative structure-activity relationship (QSAR) of cis-bis{5-[(E)-2-(aryl)-1-diazenyl]quinolinolato}di-n-butyltin(IV) complexes, (n)Bu2Sn(L)2.
Basu Baul TS; Mizar A; Chandra AK; Song X; Eng G; Jirásko R; Holcapek M; de Vos D; Linden A
J Inorg Biochem; 2008 Sep; 102(9):1719-30. PubMed ID: 18571240
[TBL] [Abstract][Full Text] [Related]
9. Macrocyclic diorganotin complexes of gamma-amino acid dithiocarbamates as hosts for ion-pair recognition.
Cruz-Huerta J; Carillo-Morales M; Santacruz-Juárez E; Hernández-Ahuactzi IF; Escalante-García J; Godoy-Alcantar C; Guerrero-Alvarez JA; Höpfl H; Morales-Rojas H; Sánchez M
Inorg Chem; 2008 Nov; 47(21):9874-85. PubMed ID: 18841933
[TBL] [Abstract][Full Text] [Related]
10. Diorganotin(IV) N-acetyl-L-cysteinate complexes: synthesis, solid state, solution phase, DFT and biological investigations.
Pellerito L; Prinzivalli C; Casella G; Fiore T; Pellerito O; Giuliano M; Scopelliti M; Pellerito C
J Inorg Biochem; 2010 Jul; 104(7):750-8. PubMed ID: 20421134
[TBL] [Abstract][Full Text] [Related]
11. Systematic differences in electrochemical reduction of the structurally characterized anti-cancer platinum(IV) complexes [Pt{((p-HC6F4)NCH2)2}-(pyridine)2Cl2], [Pt{((p-HC6F4)NCH2)2}(pyridine)2(OH)2], and [Pt{((p-HC6F4)NCH2)2}(pyridine)2(OH)Cl].
Guo SX; Mason DN; Turland SA; Lawrenz ET; Kelly LC; Fallon GD; Gatehouse BM; Bond AM; Deacon GB; Battle AR; Hambley TW; Rainone S; Webster LK; Cullinane C
J Inorg Biochem; 2012 Oct; 115():226-39. PubMed ID: 22921430
[TBL] [Abstract][Full Text] [Related]
12. Singlet diradical complexes of chromium, molybdenum, and tungsten with azo anion radical ligands from M(CO)6 precursors.
Sanyal A; Chatterjee S; Castiñeiras A; Sarkar B; Singh P; Fiedler J; Zális S; Kaim W; Goswami S
Inorg Chem; 2007 Oct; 46(21):8584-93. PubMed ID: 17887746
[TBL] [Abstract][Full Text] [Related]
13. The triphenyltin(VI) complexes of NSAIDs and derivatives. Synthesis, crystal structure and antiproliferative activity. Potent anticancer agents.
Dokorou V; Primikiri A; Kovala-Demertzi D
J Inorg Biochem; 2011 Feb; 105(2):195-201. PubMed ID: 21194618
[TBL] [Abstract][Full Text] [Related]
14. Tri- and diorganotin(IV) complexes of biologically important orotic acid: synthesis, spectroscopic studies, in vitro anti-cancer, DNA fragmentation, enzyme assays and in vivo anti-inflammatory activities.
Nath M; Vats M; Roy P
Eur J Med Chem; 2013 Jan; 59():310-21. PubMed ID: 23266665
[TBL] [Abstract][Full Text] [Related]
15. An in vitro comparative assessment with a series of new triphenyltin(IV) 2-/4-[(E)-2-(aryl)-1-diazenyl]benzoates endowed with anticancer activities: structural modifications, analysis of efficacy and cytotoxicity involving human tumor cell lines.
Basu Baul TS; Paul A; Pellerito L; Scopelliti M; Duthie A; de Vos D; Verma RP; Englert U
J Inorg Biochem; 2012 Feb; 107(1):119-28. PubMed ID: 22182574
[TBL] [Abstract][Full Text] [Related]
16. Diastereomerically pure platinum(II) complexes as antitumoral agents.: The influence of the mode of binding {(N), (N,O)- or (C,N)}- of (1S,2R)[(η5-C5H5)Fe{(η5-C5H4)CHNCH(Me)CH(OH)C6H5}] and the arrangement of the auxiliary ligands.
Talancón D; López C; Font-Bardía M; Calvet T; Quirante J; Calvis C; Messeguer R; Cortés R; Cascante M; Baldomà L; Badia J
J Inorg Biochem; 2013 Jan; 118():1-12. PubMed ID: 23123334
[TBL] [Abstract][Full Text] [Related]
17. New organotin(IV) ascorbates: synthesis, spectral characterization, biological and potentiometric studies.
Nath M; Jairath R; Eng G; Song X; Kumar A
Spectrochim Acta A Mol Biomol Spectrosc; 2005 Jan; 61(1-2):77-86. PubMed ID: 15556424
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, spectroscopic characterization and reactivity studies of oxovanadium(IV) complexes with bulky N,N'-polymethylenebis(3,5-(t)Bu(2)salicylaldimine) ligands.
Kasumov VT; Köksal F; Aslanoglu M; Yerli Y
Spectrochim Acta A Mol Biomol Spectrosc; 2010 Oct; 77(3):630-7. PubMed ID: 20674475
[TBL] [Abstract][Full Text] [Related]
19. Reactions of in situ generated hydrated organotin cations with chelating O,O- or O,N-ligands: a possible structure-directing influence of the organic substituent on tin.
Chandrasekhar V; Singh P
Dalton Trans; 2011 Jan; 40(1):114-23. PubMed ID: 21085724
[TBL] [Abstract][Full Text] [Related]
20. One-step preparation, structural assignment, and X-ray study of 2,2-di-n-butyl- and 2,2-diphenyl-6-aza-1,3-dioxa-2-stannabenzocyclononen-4-ones derived from amino acids.
Beltrán HI; Zamudio-Rivera LS; Mancilla T; Santillan R; Farfán N
Chemistry; 2003 May; 9(10):2291-306. PubMed ID: 12772304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
